Bakul is the co-founder and CEO of ImmTune Therapies. Bakul’s technical knowledge in biomaterials, nanomaterials and chemistry has laid the foundation of ImmTune’s technology enabling us to explore in vivo cell therapy.

Bakul has participated in various entrepreneurial programmes during her PhD and postdoc, and has won several awards for her work. The most recent ones include her mention as the Top 5 biotech entrepreneurs of Asian origin, and has also been recognised as one of the top 30 entrepreneurs in UK life sciences and healthcare. 

Growing up in a family of clinicians and participating in entrepreneurial programmes, Bakul has learnt the value healthcare brings to communities and is passionate about using her experience to build a product which improves patients’ lives.

Bakul completed her PhD from UNSW Australia followed by a GSK-funded Postdoctoral fellowship at Imperial College London.